Form 8-K Bunge Global SA For: Feb 05
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- Wall St set to gain on tech rebound, Middle East in focus
- SpaceX prices historic IPO at $135/share in largest ever new listing
- Oil drops as Trump cancels planned strikes against Iran
- Intel rallies as BofA double-upgrades stock on increased CPU, foundry visibility
- Oppenheimer sees little strategic case for Tesla-SpaceX merger
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Axsome Therapeutics (AXSM) PT Raised to $380 at Jefferies
Bunge (BG) PT Lowered to $76 at Citi
February 5, 2025 2:05 PM ESTCiti analyst Thomas Palmer lowered the price target on Bunge (NYSE: BG) to $76.00 (from $86.00) while maintaining a Neutral rating.
The analyst comments "Following a 4Q EPS miss and 2025 EPS outlook below the Visible Alpha consensus (initial take), the BG shares were down... More
